Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance
title

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits

 

escrs app advert yo advert

Clinical outcomes of MyoRing implantation vs combined corneal collagen cross-linking and MyoRing implantation in patients with keratoconus

Search Title by author or title

Session Details

Session Title: Cornea Surgical II

Session Date/Time: Tuesday 13/09/2016 | 08:00-10:30

Paper Time: 08:34

Venue: Hall C2

First Author: : S.Mojalad Nobari SPAIN

Co Author(s): :    C. Villena   K. Jadidi                 

Abstract Details

Purpose:

To compare combined MyoRing implantation with previously corneal collagen cross-linking (CXL- MyoRing) versus MyoRing implantation alone in patients with keratoconus.

Setting:

Bina Eye Hospital, Tehran, Iran

Methods:

This retrospective comparative study included 33 eyes of 33 patients with keratoconus stage II and III according to Amsler-Krumeich classification. Two groups were performed for this study with 1 year follow up. The group 1 received MyoRing implantation and the group 2 received CXL approximately 11 months before MyoRing implantation. All patients had a complete pre and post-operative examination including visual, refractive and keratometry examinations.

Results:

In Group 1 at the end of follow up the mean UDVA and CDVA improved by 9 and 4 lines of logMAR. In Group 2 the mean UDVA and CDVA improved by 8 and 2 lines of logMAR. There was not observed a statistically significant difference between mean UDVA of two groups postoperatively (p = 0.142) whereas the mean CDVA in Group 2 was significantly better than mean Group 1 at the end of follow up (p= 0.018). The mean keratometric values also were reduced in both groups at the end of follow up which no statistically significant difference was observed between two groups.

Conclusions:

Both MyoRing implantation alone and combined MyoRing implantation with previously CXL were safe and effective methods for moderate and severe keratoconus and resulted in similar clinical outcomes after one year follow up. Exclusively MyoRing implantation alone demonstrated better outcome in mean CDVA.

Financial Disclosure:

NONE

Back to previous